Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
10/11/2026
|
5-day change | 1st Jan Change | ||
| 203,000.00 KRW | -3.33% |
|
+6.90% | +17.76% |
| 11-10 | Celltrion's Stekima Wins EU Backing for Expanded Use in Children | MT |
| 11-03 | Celltrion Gets European Approval for Rheumatoid Arthritis Drug Trial | MT |
| Market Cap | 46,372B 34.5B 30.94B 28.52B 25.9B 49.01B 3,235B 50.38B 341B 136B 1,733B 129B 127B 5,479B | P/E 2026 * |
34.4x | P/E 2027 * | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 48.94B 36.41M 32.65M 30.09M 27.33M 51.72M 3.41B 53.17M 360M 144M 1.83B 137M 134M 5.78B | EV / Sales 2026 * |
8.51x | EV / Sales 2027 * | 7.35x |
| Free-Float |
58.02% | Yield 2026 * |
0.38% | Yield 2027 * | 0.4% |
| 1 day | -3.33% | ||
| 1 week | +6.90% | ||
| Current month | +5.95% | ||
| 1 month | +13.03% | ||
| 3 months | +1.00% | ||
| 6 months | +7.43% | ||
| Current year | +17.76% |
| 1 week | 202,000 |  | 216,000 |
| 1 month | 173,700 | | 216,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 135,879.99 | | 239,047.62 |
| 5 years | 114,250.83 | | 239,047.62 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 51 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 69 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/01/26 | Sell | 500 | 0.0002% | |||
| 16/01/26 | Sell | 1,000 | 0.0004% | |||
| 16/01/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.33% | +6.90% | +22.78% | +48.07% | 34.5B | |
| +0.01% | +11.10% | +60.83% | +70.43% | 68.32B | |
| +0.76% | +6.80% | +14.14% | +89.18% | 60.26B | |
| -0.06% | 0.00% | +19.68% | +97.14% | 55.86B | |
| +1.60% | +19.44% | +28.80% | +112.95% | 48.43B | |
| -1.32% | +4.78% | +29.15% | +40.40% | 45.34B | |
| -3.54% | -0.60% | +207.76% | +879.50% | 41.76B | |
| -1.31% | -1.34% | +83.95% | +56.33% | 33.8B | |
| -1.49% | +1.16% | +47.05% | +0.16% | 25.96B | |
| +2.92% | +14.41% | -37.74% | +403.12% | 26.21B | |
| Average | -0.58% | +6.30% | +47.64% | +179.73% | 44B | |
| Weighted average by Cap. | -0.48% | +5.80% | +48.49% | +167.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,751B 4.28B 3.84B 3.54B 3.21B 6.08B 401B 6.25B 42.35B 16.87B 215B 16.06B 15.72B 680B | 6,561B 4.88B 4.38B 4.03B 3.66B 6.93B 458B 7.13B 48.31B 19.25B 245B 18.32B 17.93B 775B |
| Net income | 1,341B 998M 895M 825M 749M 1.42B 93.57B 1.46B 9.88B 3.93B 50.13B 3.75B 3.67B 158B | 1,814B 1.35B 1.21B 1.12B 1.01B 1.92B 127B 1.97B 13.35B 5.32B 67.79B 5.06B 4.96B 214B |
| Net Debt | 2,566B 1.91B 1.71B 1.58B 1.43B 2.71B 179B 2.79B 18.89B 7.53B 95.89B 7.16B 7.01B 303B | 1,849B 1.38B 1.23B 1.14B 1.03B 1.95B 129B 2.01B 13.62B 5.42B 69.11B 5.16B 5.05B 218B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | ₩203,000.00 | -3.33% | 869,506 |
| 09/11/26 | ₩210,000.00 | -0.47% | 626,672 |
| 06/11/26 | ₩211,000.00 | -1.86% | 1,036,846 |
| 05/11/26 | ₩215,000.00 | +7.50% | 1,999,977 |
| 04/11/26 | ₩200,000.00 | +5.32% | 1,091,653 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
